Cargando…

Early Antimicrobial De-escalation Is Associated with Decreased Acute Kidney Injury in Patients Receiving Empiric Combination Therapy

BACKGROUND: Combination antimicrobial therapy is often initiated for empiric treatment of infections. Recently, vancomycin (VAN) and piperacillin-tazobactam (TZP) therapy has been linked to increases in acute kidney injury (AKI). The objective of this study was to determine whether antimicrobial de-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rutter, W Cliff, Burgess, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631197/ http://dx.doi.org/10.1093/ofid/ofx163.1244

Ejemplares similares

Acute Kidney Injury Associated with Combination Antimicrobial Therapy in the Medical Information Mart for Intensive Care (MIMIC) III Database
por: Rutter, W Cliff, et al.
Publicado: (2017)

Incidence of Acute Kidney Injury Among Intensive Care Unit Patients Receiving Vancomycin in Combination with Cefepime or Piperacillin–Tazobactam
por: Rutter, W Cliff, et al.
Publicado: (2017)

Is There a Significant Difference in Acute Kidney Injury Incidence Among Patients Treated with Vancomycin Combined with Cefepime or Meropenem?
por: Rutter, W Cliff, et al.
Publicado: (2017)

Impact of Obesity on Acute Kidney Injury Incidence Among Patients Treated with Piperacillin–Tazobactam and Vancomycin
por: Rutter, W Cliff, et al.
Publicado: (2017)

1090. Practicing Antimicrobial Stewardship: De-escalating Empiric Antibiotics in Patients with Acute Myelogenous Leukemia and Neutropenic Fever
por: Fuller, Risa, et al.
Publicado: (2019)

2558. Association of Vancomycin-Induced Acute Kidney Injury with Trough Versus AUC Monitoring in Patients Receiving Extended Durations of Therapy
por: Pitcock, C Tyler, et al.
Publicado: (2023)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program
por: Liu, Peter, et al.
Publicado: (2016)

1224. Outcomes of Empirical Vancomycin De-escalation Based on Methicillin-Resistant Staphylococcus aureus Nares
por: Xu, Jiachen, et al.
Publicado: (2023)

1807. The Impact of Rapid Diagnostic Testing and Antimicrobial Stewardship on the Time to Escalation/De-escalation of Antimicrobial Regimens for Gram-Negative Bloodstream Infections at a Large Community Hospital
por: Gawrys, Gerard W, et al.
Publicado: (2018)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

The influence of empiric antimicrobial therapy on acquired pulmonary infection in patients with a chest injury on ICU
por: Chytra, I, et al.
Publicado: (2000)

109. Impact of Accelerate Pheno(TM) System on Time to De-escalation of Antimicrobial Therapy
por: Powers, Caroline, et al.
Publicado: (2020)

2292. Incidence of Acute Kidney Injury Associated with Duration of Vancomycin and Piperacillin/tazobactam Combination Therapy
por: McMullen, Lisanne, et al.
Publicado: (2019)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023)

133. Impact of the BioFire FilmArray Blood Culture Identification 2 (BCID2) Panel on Time to Antimicrobial Escalation or De-escalation in a Community Health System
por: DelRusso, Katie, et al.
Publicado: (2023)

Comparison of Rates of Acute Kidney Injury with Vancomycin/Piperacillin-Tazobactam vs. Vancomycin/Meropenem Combination Therapy
por: Pernia, Sonia, et al.
Publicado: (2017)

Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy
por: Awdishu, Linda, et al.
Publicado: (2018)

2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia
por: Davis, Matthew, et al.
Publicado: (2019)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019)

2877. Influence of vancomycin AUC monitoring on acute kidney injury in a large quasi-experimental study of over 3000 patients
por: Gregory, Eric, et al.
Publicado: (2023)

1509. Outcomes of Empirical Antimicrobial Therapy for Pediatric Community-Onset Febrile Urinary Tract Infection in the Era of Increasing Antimicrobial Resistance
por: Kantamalee, Worawit, et al.
Publicado: (2019)

342. Time to Antimicrobial De-escalation/Discontinuation After Implementation of Cerebrospinal Fluid Polymerase Chain Reaction Tool
por: Chicoineau, Michelle, et al.
Publicado: (2018)

163. Assessment of Pneumonia FilmArray Use on the Impact on Antimicrobial De-escalation Within an Integrated Health System
por: Weichman, Brittani, et al.
Publicado: (2022)

391. Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
por: Medler, Corey J, et al.
Publicado: (2020)

1670. It Is Likely Not HSV: Decreasing Empiric Acyclovir Use In Low-Risk Infants
por: Junquera, Guillermo Yepes, et al.
Publicado: (2023)

2282. Empiric Antimicrobial Therapy and Clinical Outcomes of Infections due to ESBL-producing Klebsiella pneumoniae
por: Wendy Fujita, Ayako, et al.
Publicado: (2019)

De-escalation of empiric antibiotic therapy in sepsis - an indian observational study
por: Jakkinaboina, S, et al.
Publicado: (2015)

2734. Evaluation of Empiric Antimicrobial Therapy for End-Stage Liver Disease Patients at an Academic Medical Center
por: Kim, Annie, et al.
Publicado: (2023)

1238. Evaluating the Impact of an Automatic Antibiotic De-escalation Protocol at an Acute Care Hospital
por: Diep, Albert, et al.
Publicado: (2023)

212. Acute Kidney Injury with Piperacillin-tazobactam versus Cefepime in Combination with Vancomycin
por: Nguyen, Phuong Khanh, et al.
Publicado: (2020)

400. Comparison of Tolerance and Microbiological Efficacy of Cefepime and Piperacillin/Tazobactam in Combination with Vancomycin as Empirical Antimicrobial Therapy of Prosthetic Joint Infection: A Propensity-Matched Cohort Study
por: Triffault-Fillit, Claire, et al.
Publicado: (2019)

2669. Evaluation of Post-Operative Acute Kidney Injury with Piperacillin–Tazobactam Combined with Vancomycin for Lung Transplant Prophylaxis
por: Pettit, Natasha N, et al.
Publicado: (2019)

2043. The “Resistance Calculator”: Refining Empiric Practices of Antimicrobials Prescription in the Era of Widespread Resistance
por: Zilberman-Itskovich, Shani, et al.
Publicado: (2019)

1253. Optimization of empiric gram-negative infections with the combination antibiogram
por: Leung, Anthony K, et al.
Publicado: (2023)

1999. Does Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus PCR Nasal Screening Decrease Time to De-Escalation of MRSA Coverage in Patients with Pneumonia?
por: Waters, Dustin, et al.
Publicado: (2019)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
por: Nichols, Courtney, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfomi289jr2ldfhc87u803jlb3